Pharmacological treatments of pathological gambling

Eric Hollander; Erica Sood; Stefano Pallanti; Nicolo Baldini-Rossi; Bryann Baker

doi:10.1007/s10899-004-1932-8

Pharmacological treatments of pathological gambling

Eric Hollander, Erica Sood, Stefano Pallanti, Nicolo Baldini-Rossi, Bryann Baker

Research output: Contribution to journal › Article › peer-review

56 Scopus citations

Abstract

Medication treatment studies have demonstrated short-term efficacy of various SRIs, opioid antagonists, and mood stabilizers in sub-samples of adult treatment seeking pathological gamblers. Pathological gambling is frequently comorbid with bipolar spectrum disorders, substance abuse/dependence, and attention-deficit/hyperactivity disorder (ADHD), and comorbidity may influence treatment response in pathological gambling. This review focuses on recent research examining the treatment of pathological gambling and highlights methodological challenges for future studies.

Original language	English
Pages (from-to)	101-110
Number of pages	10
Journal	Journal of Gambling Studies
Volume	21
Issue number	1
DOIs	https://doi.org/10.1007/s10899-004-1932-8
State	Published - Mar 2005

Keywords

Fluoxamine
Lithium
PG-YBOCS
Pathological gambling
SSRI

Access to Document

10.1007/s10899-004-1932-8

Cite this

@article{75a474df36ed4216aae7fafc7bff23ce,

title = "Pharmacological treatments of pathological gambling",

abstract = "Medication treatment studies have demonstrated short-term efficacy of various SRIs, opioid antagonists, and mood stabilizers in sub-samples of adult treatment seeking pathological gamblers. Pathological gambling is frequently comorbid with bipolar spectrum disorders, substance abuse/dependence, and attention-deficit/hyperactivity disorder (ADHD), and comorbidity may influence treatment response in pathological gambling. This review focuses on recent research examining the treatment of pathological gambling and highlights methodological challenges for future studies.",

keywords = "Fluoxamine, Lithium, PG-YBOCS, Pathological gambling, SSRI",

author = "Eric Hollander and Erica Sood and Stefano Pallanti and Nicolo Baldini-Rossi and Bryann Baker",

note = "Funding Information: Some of the research included in this manuscript was supported in part by NIDA (5 RO1 DA10234-03), Solvay Pharmaceuticals, and a grant (5 MO1 RR00071) for the Mount Sinai General Clinical Research Center from the National Center for Research Resources, National Institutes of Health.",

year = "2005",

month = mar,

doi = "10.1007/s10899-004-1932-8",

language = "English",

volume = "21",

pages = "101--110",

journal = "Journal of Gambling Studies",

issn = "1050-5350",

publisher = "Springer International Publishing AG",

number = "1",

}

TY - JOUR

T1 - Pharmacological treatments of pathological gambling

AU - Hollander, Eric

AU - Sood, Erica

AU - Pallanti, Stefano

AU - Baldini-Rossi, Nicolo

AU - Baker, Bryann

N1 - Funding Information: Some of the research included in this manuscript was supported in part by NIDA (5 RO1 DA10234-03), Solvay Pharmaceuticals, and a grant (5 MO1 RR00071) for the Mount Sinai General Clinical Research Center from the National Center for Research Resources, National Institutes of Health.

PY - 2005/3

Y1 - 2005/3

N2 - Medication treatment studies have demonstrated short-term efficacy of various SRIs, opioid antagonists, and mood stabilizers in sub-samples of adult treatment seeking pathological gamblers. Pathological gambling is frequently comorbid with bipolar spectrum disorders, substance abuse/dependence, and attention-deficit/hyperactivity disorder (ADHD), and comorbidity may influence treatment response in pathological gambling. This review focuses on recent research examining the treatment of pathological gambling and highlights methodological challenges for future studies.

AB - Medication treatment studies have demonstrated short-term efficacy of various SRIs, opioid antagonists, and mood stabilizers in sub-samples of adult treatment seeking pathological gamblers. Pathological gambling is frequently comorbid with bipolar spectrum disorders, substance abuse/dependence, and attention-deficit/hyperactivity disorder (ADHD), and comorbidity may influence treatment response in pathological gambling. This review focuses on recent research examining the treatment of pathological gambling and highlights methodological challenges for future studies.

KW - Fluoxamine

KW - Lithium

KW - PG-YBOCS

KW - Pathological gambling

KW - SSRI

UR - http://www.scopus.com/inward/record.url?scp=17644392438&partnerID=8YFLogxK

U2 - 10.1007/s10899-004-1932-8

DO - 10.1007/s10899-004-1932-8

M3 - Article

C2 - 15789195

AN - SCOPUS:17644392438

SN - 1050-5350

VL - 21

SP - 101

EP - 110

JO - Journal of Gambling Studies

JF - Journal of Gambling Studies

IS - 1

ER -

Pharmacological treatments of pathological gambling

Abstract

Keywords

Access to Document

Fingerprint

Cite this